GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 177 filers reported holding GENMAB A/S in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $501,864 | -99.9% | 11,842 | -46.4% | 0.00% | 0.0% |
| Q3 2022 | $355,355,000 | +110602.5% | 22,094 | +123.3% | 0.00% | +33.3% |
| Q2 2022 | $321,000 | -3.9% | 9,895 | +7.2% | 0.00% | 0.0% |
| Q1 2022 | $334,000 | -6.7% | 9,234 | +2.2% | 0.00% | -25.0% |
| Q4 2021 | $358,000 | -24.2% | 9,039 | -16.4% | 0.00% | -20.0% |
| Q3 2021 | $472,000 | +23.9% | 10,809 | +15.9% | 0.01% | +25.0% |
| Q2 2021 | $381,000 | +46.5% | 9,325 | +17.6% | 0.00% | +33.3% |
| Q1 2021 | $260,000 | – | 7,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |